Diabetes Care Devices - Ireland | Statista Market Forecast

In Ireland, revenue in the Diabetes Care Devices market market is projected to reach US$95.93m in 2024.
The revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 11.56%.
This growth is expected to lead to a market volume of US$165.80m by 2029.
When compared globally, the largest revenue is expected to be generated the United States, with a projected figure of US$11.71bn in 2024.
In Ireland, the Diabetes Care Devices market is increasingly integrating advanced digital health solutions, enhancing patient engagement and self-management capabilities.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Ireland is witnessing considerable growth, fueled by rising prevalence of diabetes, advancements in technology, and increased demand for effective monitoring solutions, enhancing patient outcomes and overall healthcare efficiency.

Customer preferences: Consumers in Ireland are increasingly prioritizing personalized diabetes management solutions, reflecting a cultural shift toward individualized healthcare. The rise of smart insulin pens and continuous glucose monitors caters to this demand, offering real-time data and insights. Additionally, demographic changes, such as an aging population, are prompting a focus on user-friendly devices that simplify diabetes care. The integration of mobile apps for data tracking and community support is also gaining traction, as patients seek more connected and informed health management experiences.

Trends in the market: In Ireland, the Diabetes Care Devices Market is experiencing a surge in demand for advanced diabetes management technologies, particularly smart insulin pens and continuous glucose monitors. This trend reflects a broader shift towards personalized healthcare, enabling patients to take control of their condition with real-time data and insights. Additionally, the aging population is driving the need for user-friendly devices that simplify diabetes care. The integration of mobile applications for data tracking and community support is becoming increasingly popular, enhancing patient engagement and fostering a connected health management ecosystem. These developments present significant opportunities for industry stakeholders, including device manufacturers and healthcare providers, to innovate and meet the evolving needs of diabetes patients.

Local special circumstances: In Ireland, the Diabetes Care Devices Market is shaped by a strong emphasis on patient-centric healthcare and a robust regulatory framework that promotes the adoption of innovative medical technologies. The country's commitment to universal healthcare and access to services creates a conducive environment for diabetes care devices, particularly among the aging population, which has a higher prevalence of diabetes. Additionally, Ireland's tech-savvy culture encourages the integration of digital health solutions, such as mobile apps for data management, fostering improved patient engagement and adherence to treatment plans.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Ireland is significantly shaped by macroeconomic factors such as national economic stability, healthcare investment, and demographic trends. The country's robust economic growth fosters increased public and private funding for healthcare initiatives, enhancing the adoption of advanced diabetes care technologies. Furthermore, Ireland's focus on fiscal policies that prioritize health expenditure supports the development of innovative medical devices. Global economic trends, including rising healthcare costs and an increasing prevalence of diabetes, further drive demand for efficient and effective diabetes management solutions, particularly among the aging population. As a result, the market is poised for continued growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.